PTI is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Filing Variations

15 - 16 June 2020

Barbizon Palace, Amsterdam, The Netherlands

Managing regulatory change for filing variations is a complex and challenging procedure. The regulatory requirements highlight the need for successful variations strategies across regulatory teams. It is therefore important for you to understand the regulations, definitions and best practice for implementation.  
 
This two day course will teach you how to optimise your procedures for faster, streamlined and compliant variation submissions. The course contains exercises and case studies to help you understand the variation requirements and meet your regulatory goals. You will examine the various types of variations from mutual recognition to type II and centralised procedure variations. You will also discuss how best to approach grouping and worksharing so you know when to apply it to your variations.  

Clarify the latest Variations revisions:

  • Formulate Variations procedures that achieve faster approval
  • Manage the practical hurdles of submitting your Variations on time and with the right supporting data
  • Understand the impact of the CTD on your Variation dossier
  • Collect and present complete information on your Variations
  • Streamline your Variation procedures for international applications
  • Tackle the challenges of type II Variations under the MRP


Sumaiya Patel

Sumaiya Patel is a director of a regulatory consultancy with over 11 years’ experience in both pre and post-approvals for generic, CRO and big pharma organisations. Sumaiya has experience in regulatory implementation and training, focusing on CMC, clinical development, strategy and manufacturing. She has extensive experience in writing Module 3 of CTD, Module 2 of the CTD and also Quality Expert statements to support dossiers and Type II Quality variations. She has a track record of providing regulatory inputs related to CMC aspects during the development product lifecycle.

This course will be beneficial to Regulatory Affairs personnel who take part in filing variations such as:

  • Regulatory Affairs
  • Dossier registration department
  • Product Information
  • RA compliance
  • Personnel from other disciplines who have an impact on the process of filing Variations, such as manufacturing, development, clinical safety and pharmacovigilance.

“The case studies were refreshing and gave the opportunity to think and use information we learned from the experience. Thanks a lot for the good training course!” Regulatory Affairs Manager, Takeda Latvia

“The interactive aspect and the practical sessions were particularly enjoyable.” Regulatory Affairs Executive, Bimeda

We're looking forward to welcoming our attendees and expert course leaders at Filing Variations
in Amsterdam in June.

Our number one priority is the safety of our delegates and colleagues, and there are always measures in place at our venues to safeguard your health and safety. There are extra measures in place for 2020 in light of developments with COVID-19.

Book with total confidence – click here to be fully assured on how your booking rights are protected.

The interaction and discussion of the particular ‘real-life’ examples as well as sharing experiences with different countries was very beneficial.

Senior Regulatory Affairs Officer, HAL Allergy


The fact that there were small groups, with great content and hands-on exercises, made it a very good course.

Global CMC Regulatory Affairs Consultant, Bioreg Consultancy Limited